0000950170-25-091759.txt : 20250630 0000950170-25-091759.hdr.sgml : 20250630 20250630174925 ACCESSION NUMBER: 0000950170-25-091759 CONFORMED SUBMISSION TYPE: 4/A PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20211229 FILED AS OF DATE: 20250630 DATE AS OF CHANGE: 20250630 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Valantine Hannah CENTRAL INDEX KEY: 0001855608 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4/A SEC ACT: 1934 Act SEC FILE NUMBER: 001-38959 FILM NUMBER: 251093508 MAIL ADDRESS: STREET 1: 1305 O'BRIEN DRIVE CITY: MENLO PARK STATE: CA ZIP: 94025 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: BridgeBio Pharma, Inc. CENTRAL INDEX KEY: 0001743881 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences EIN: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 3160 PORTER DR. STREET 2: SUITE 250 CITY: PALO ALTO STATE: CA ZIP: 94304 BUSINESS PHONE: (650) 391-9740 MAIL ADDRESS: STREET 1: 3160 PORTER DR. STREET 2: SUITE 250 CITY: PALO ALTO STATE: CA ZIP: 94304 FORMER COMPANY: FORMER CONFORMED NAME: BridgeBio Pharma LLC DATE OF NAME CHANGE: 20180618 4/A 1 ownership.xml 4/A X0508 4/A 2021-12-29 2022-01-03 0001743881 BridgeBio Pharma, Inc. BBIO 0001855608 Valantine Hannah C/O BRIDGEBIO PHARMA, INC. 3160 PORTER DR., SUITE 250 PALO ALTO CA 94304 true false false false false Common Stock 2021-12-29 4 P false 1752 14.24 A 3294 D Common Stock 2687 I By Spouse /s/ Hannah A. Valantine, M.D. 2025-06-30